NCT07390045 Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors
| NCT ID | NCT07390045 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Rochester |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-07-31 |
| Primary Completion | 2028-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-07-31 with a primary completion date of 2028-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to assess the preliminary effects of an integrated exercise and cognitive rehabilitation intervention (ECO), an exercise intervention (EXCAP), and a cognitive rehabilitation intervention (MAAT) as compared to usual care on objective cognition (Trail Making Test).
Eligibility Criteria
Inclusion criteria: * Age ≥65 years (from date of consent, confirmed on the electronic medical record) * A diagnosis of any cancer * Have completed curative intent treatments * Patients on endocrine therapies are allowed to enroll * Patients with hematologic malignancies after autologous or allogeneic stem cell transplant are allowed to enroll if they have completed curative-intent treatment * Answered "yes" to the verbal question "Do you have concerns about memory or other thinking abilities following your cancer treatment?" * Able to speak English (interventions are available in English only) * Eastern Cooperative Oncology Group (ECOG) performance status of 0-3# * No medical contraindications to exercise# * Able to walk 4 meters# * Able to provide informed consent# * Confirmed through eligibility confirmation with the patient's oncologist or their designee Exclusion criteria: * Any physical, psychological, or social impairments that would interfere with a patient's ability to participate in the study as determined by the patient's oncologist or their designee * Unwilling to complete study procedures
Contact & Investigator
Kah Poh Loh
PRINCIPAL INVESTIGATOR
University of Rochester
Frequently Asked Questions
Who can join the NCT07390045 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07390045 currently recruiting?
Yes, NCT07390045 is actively recruiting participants. Contact the research team at Kahpoh_Loh@URMC.Rochester.edu for enrollment information.
Where is the NCT07390045 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT07390045 clinical trial?
NCT07390045 is sponsored by University of Rochester. The principal investigator is Kah Poh Loh at University of Rochester. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.